{"transactions":[{"id":961097,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:15.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-124536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124536/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985188,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:16.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-116678","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116678/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033842,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:26.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents restricted stock awards granted on September 19, 2025 to the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001213900-25-090617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090617/ownership.xml","form_type":"4"}},{"id":1033841,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:26.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-090617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090617/ownership.xml","form_type":"4"}},{"id":1068703,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":22344,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":22344,"derivative":{"exercise_price":19.25,"expiration_date":"2026-09-27","underlying":"Common Stock","underlying_shares":22344},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068702,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22344,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":19.25,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":22344},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068701,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":31373,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":31373,"derivative":{"exercise_price":28.75,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":31373},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068700,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31373,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":28.75,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":31373},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1330942,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:06.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":50000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-109304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109304/ownership.xml","form_type":"4"}},{"id":1330941,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:06.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-24-109304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109304/ownership.xml","form_type":"4"}},{"id":1368599,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-12T17:00:18.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":75000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-24-096888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024096888/ownership.xml","form_type":"4"}},{"id":1368598,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:18.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001213900-24-096888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024096888/ownership.xml","form_type":"4"}},{"id":1398394,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":558597,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":558597,"derivative":{"exercise_price":0.77,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":558597},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398393,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-09-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":558597,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":558597},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398392,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":784314,"derivative":{"exercise_price":1.15,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398391,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2024-08-14","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1419061,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:13.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":1500000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001213900-24-074518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074518/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1433855,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:28:37.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":500000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-24-069250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069250/ownership.xml","form_type":"4"}},{"id":1546544,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:20.000Z","date":"2024-04-03","kind":"grant","planned":false,"acquired":true,"shares":129450,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":129450,"derivative":{"exercise_price":1.42,"expiration_date":"2025-04-05","underlying":"Common Stock","underlying_shares":129450},"source":{"system":"sec-edgar","filing":"0001213900-24-030812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024030812/ownership.xml","form_type":"4"}},{"id":1546543,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:20.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":129450,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2024-04-05","underlying":"Common Stock","underlying_shares":129450},"source":{"system":"sec-edgar","filing":"0001213900-24-030812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024030812/ownership.xml","form_type":"4"}},{"id":1761047,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T16:15:31.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001013762-23-003533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000101376223003533/ownership.xml","form_type":"4"}},{"id":2141115,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T16:08:55.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-22-062483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390022062483/ownership.xml","form_type":"4"}},{"id":2543254,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:47.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":15000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-052678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021052678/ownership.xml","form_type":"4"}},{"id":2543253,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:47.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":650000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001213900-21-052678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021052678/ownership.xml","form_type":"4"}},{"id":2624781,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:58.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":10000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-21-038696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021038696/ownership.xml","form_type":"4"}},{"id":2624780,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:58.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-038696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021038696/ownership.xml","form_type":"4"}},{"id":2698717,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T20:59:46.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 20, 2022 and (2) the date of the Issuer's 2022 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.03,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-035388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919121035388/doc4.xml","form_type":"4"}},{"id":3009299,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:08:18.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-20-030794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390020030794/ownership.xml","form_type":"4"}},{"id":3110441,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T20:41:31.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 11, 2021 and (2) the date of the Issuer's 2021 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.47,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000120919120036632/doc4.xml","form_type":"4"}},{"id":3394648,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:09:01.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":175000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001213900-19-020115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390019020115/ownership.xml","form_type":"4"}},{"id":3405111,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-09-27T16:15:30.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":558597,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":558597,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":558597},"source":{"system":"sec-edgar","filing":"0001213900-19-019177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390019019177/ownership.xml","form_type":"4"}},{"id":3405110,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-27T16:15:30.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":558597,"price":0.8951,"value":500000.1747,"ownership":{"direct":true},"balance_after":1992243,"source":{"system":"sec-edgar","filing":"0001213900-19-019177","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390019019177/ownership.xml","form_type":"4"}},{"id":3520653,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-17T23:33:34.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the option will vest upon the earlier of (i) May 17, 2020 and (ii) the date of the Issuer's 2020 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":15.22,"expiration_date":"2029-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-027158","document":"tv521924_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420419027158/tv521924_4.xml","form_type":"4"}},{"id":3561179,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-04-05T16:06:19.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":129450,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":129450,"derivative":{"exercise_price":1.42,"expiration_date":"2021-04-05","underlying":"Common Stock","underlying_shares":129450},"source":{"system":"sec-edgar","filing":"0001213900-19-005843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390019005843/ownership.xml","form_type":"4"}},{"id":3561178,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-05T16:06:19.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":129450,"price":1.545,"value":200000.25,"ownership":{"direct":true},"balance_after":1433646,"source":{"system":"sec-edgar","filing":"0001213900-19-005843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390019005843/ownership.xml","form_type":"4"}},{"id":3823139,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2018-09-06T16:10:08.000Z","date":"2018-09-04","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.62,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-18-012192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390018012192/ownership.xml","form_type":"4"}},{"id":3843154,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-08-15T17:06:13.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":784314,"derivative":{"exercise_price":1.15,"expiration_date":"2023-08-14","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001213900-18-011211","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390018011211/ownership.xml","form_type":"4"}},{"id":3843153,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-15T17:06:13.000Z","date":"2018-08-13","kind":"purchase","acquired":true,"shares":784314,"price":1.275,"value":1000000.35,"ownership":{"direct":true},"balance_after":1304196,"source":{"system":"sec-edgar","filing":"0001213900-18-011211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390018011211/ownership.xml","form_type":"4"}},{"id":3910592,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-01T21:46:51.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the option will vest upon the earlier of (i) May 30, 2019 and (ii) the date of the Issuer's 2019 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":42.09,"expiration_date":"2028-05-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001144204-18-032470","document":"tv495555_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420418032470/tv495555_4.xml","form_type":"4"}},{"id":3979517,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-29T18:00:36.000Z","date":"2018-03-28","kind":"purchase","acquired":true,"shares":2915,"price":3.09,"value":9007.35,"ownership":{"direct":true},"balance_after":519882,"source":{"system":"sec-edgar","filing":"0001213900-18-003691","document":"f4032818holubiak_citiuspharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390018003691/f4032818holubiak_citiuspharm.xml","form_type":"4"}},{"id":4292809,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T20:31:54.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest upon the earlier of (i) June 1, 2018 and (ii) the date of the Issuer's 2018 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":25.96,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001144204-17-031032","document":"v468318_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1426800/000114420417031032/v468318_4.xml","form_type":"4"}}]}